{"title":"Anergy in COVID-19 Infected and COVID-19 vaccinee","authors":"","doi":"10.31038/jipc.2022213","DOIUrl":"https://doi.org/10.31038/jipc.2022213","url":null,"abstract":"","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"116 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134531233","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Under the complexity and uncertainty of the COVID-19 pandemic, social distancing was found to be effective in containing the Coronavirus [1,2]. Social distancing entails isolation of people with symptoms of COVID-19; quarantines for people with confirmed COVID-19; prohibition congregations, and maintaining physical distance. Social distancing is a central non-pharmaceutical intervention for breaking the chain of infection transmission [3-6]. But compliance with social distancing is poor among members from different cultures compared to the general population [7,8]. Health authorities aspire to optimize compliance with social distancing [9,10]. Optimal compliance with social distancing emerges from personal responsibility for the greater good [11].
{"title":"A Novel Strategy for Communication to Drive Voluntary Compliance with Social Distancing in COVID-19 across Religious-Cultures in Mumbai India – The Case of ‘Cognitive Polyphasia’","authors":"G. Gabay, Preeti S. Rawat, G. G. Verma","doi":"10.31038/jipc.2022212","DOIUrl":"https://doi.org/10.31038/jipc.2022212","url":null,"abstract":"Under the complexity and uncertainty of the COVID-19 pandemic, social distancing was found to be effective in containing the Coronavirus [1,2]. Social distancing entails isolation of people with symptoms of COVID-19; quarantines for people with confirmed COVID-19; prohibition congregations, and maintaining physical distance. Social distancing is a central non-pharmaceutical intervention for breaking the chain of infection transmission [3-6]. But compliance with social distancing is poor among members from different cultures compared to the general population [7,8]. Health authorities aspire to optimize compliance with social distancing [9,10]. Optimal compliance with social distancing emerges from personal responsibility for the greater good [11].","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"38 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116926944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
COVID-19 disease spread worldwide in 2019 from Wuhan, China, for unknown reasons [1,2]. The disease was caused by the SARS-CoV-2 virus and infected many people in different parts of the world in a short time. According to global statistics, about 255 million people have been infected with the illness so far, and 5.12 million people have died from it [3]. Emergencies have led health professionals and centers to develop guidelines to prevent the transmission of the sickness chain and to treat people. Common symptoms include fever, cough, tiredness, and loss of smell or taste. In addition, patients may experience sore throat, headache, irritated eyes, and diarrhea. More severe cases of the disease can include chest pain and shortness of breath which the person should go to a doctor and hospital immediately [4]. Since its inception, the virus has shown mutations that have led to increased transmission and severity of the disease, which has ultimately increased mortality. Some obvious variants are Alpha, Beta, Gamma, and Delta species which the Delta mutation has become more intense. Although the process of universal vaccination has made humans more resistant to the virus, the disease is now leading to injury and death [5].
{"title":"Application of Artificial Intelligence in the Diagnosis and Treatment of COVID-19 Lung Disease","authors":"Jalaeian Zaferani, Teshnehlab, Nadji","doi":"10.31038/jipc.2021122","DOIUrl":"https://doi.org/10.31038/jipc.2021122","url":null,"abstract":"COVID-19 disease spread worldwide in 2019 from Wuhan, China, for unknown reasons [1,2]. The disease was caused by the SARS-CoV-2 virus and infected many people in different parts of the world in a short time. According to global statistics, about 255 million people have been infected with the illness so far, and 5.12 million people have died from it [3]. Emergencies have led health professionals and centers to develop guidelines to prevent the transmission of the sickness chain and to treat people. Common symptoms include fever, cough, tiredness, and loss of smell or taste. In addition, patients may experience sore throat, headache, irritated eyes, and diarrhea. More severe cases of the disease can include chest pain and shortness of breath which the person should go to a doctor and hospital immediately [4]. Since its inception, the virus has shown mutations that have led to increased transmission and severity of the disease, which has ultimately increased mortality. Some obvious variants are Alpha, Beta, Gamma, and Delta species which the Delta mutation has become more intense. Although the process of universal vaccination has made humans more resistant to the virus, the disease is now leading to injury and death [5].","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115421796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Analysis of the New Prescriptions Created in Our Organization during the First Twelve Months after the Declaration of the State of Alarm Due to SARS-CoV-2","authors":"","doi":"10.31038/jipc.2021112","DOIUrl":"https://doi.org/10.31038/jipc.2021112","url":null,"abstract":"","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128542423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The study reported here represents the first effort to apply the emerging science of Mind Genomics to the citizens of an entire state, with the goal of improving about the during the rather than as an academic exercise AFTER the virus. The paper presents a statewide study of responses to COVID-19, done in Arizona, USA, as preparation for the upcoming vaccine, promised for 2021. The objective is to determine the key messages which would engage Arizonans, and interest them in as preparation for a state-wide vaccination campaign. The process followed the Mind Genomics protocol, a protocol used to uncover how people think about the ordinary topics of their lives, done by exposing them to systematic combinations of messages, and determining which individual messages drove their ratings. The data confirmed previous North American findings, that there are two major mind-sets when it comes to COVID-19, the Pandemic Onlookers who are not involved and are engaged by one set of messages, and the Pandemic Citizens, who are involved, want to be guided by the government, and are engaged by another set of messages. These two mind-sets distribute throughout the population but can be quickly identified through a six-question, 30-second intervention, the PVI, Personal Viewpoint Identifier.
{"title":"Driving to Comply: Mind Genomics, Arizona, and the COVID-19 Vaccine","authors":"H. Moskowitz, A. Gere","doi":"10.31038/jipc.2021111","DOIUrl":"https://doi.org/10.31038/jipc.2021111","url":null,"abstract":"The study reported here represents the first effort to apply the emerging science of Mind Genomics to the citizens of an entire state, with the goal of improving about the during the rather than as an academic exercise AFTER the virus. The paper presents a statewide study of responses to COVID-19, done in Arizona, USA, as preparation for the upcoming vaccine, promised for 2021. The objective is to determine the key messages which would engage Arizonans, and interest them in as preparation for a state-wide vaccination campaign. The process followed the Mind Genomics protocol, a protocol used to uncover how people think about the ordinary topics of their lives, done by exposing them to systematic combinations of messages, and determining which individual messages drove their ratings. The data confirmed previous North American findings, that there are two major mind-sets when it comes to COVID-19, the Pandemic Onlookers who are not involved and are engaged by one set of messages, and the Pandemic Citizens, who are involved, want to be guided by the government, and are engaged by another set of messages. These two mind-sets distribute throughout the population but can be quickly identified through a six-question, 30-second intervention, the PVI, Personal Viewpoint Identifier.","PeriodicalId":258672,"journal":{"name":"Journal of International Perspectives on COVID-19","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130051893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：